Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-10

Clinical Trial Update: Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT) [Phase 1]

View source ↗

Summary

Phase 1 pediatric PK study of EXE844 otic suspension in children undergoing tympanostomy tube insertion has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXE844 (EXE844)

Snippet

Sponsor: Alcon Research | Conditions: Otitis Media With Effusion in Children, Otitis Media Recurrent | Phase 1 | Status: COMPLETED | Results posted: 2018-07-10